VolitionRX Limited Company Profile
NYSE: VNRXHealthcareMedical DevicesUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
VolitionRX at a glance
VolitionRX Limited (NYSE: VNRX) is a Medical Devices company in the Healthcare sector headquartered in Henderson, NV. VolitionRX is led by Mr. Cameron Reynolds MBA and employs about 57 people. The company's shares have traded publicly since 2015.
At a market capitalization of $6.6 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0000093314, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does VolitionRX do?
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is headquartered in Henderson, Nevada.
Business description based on the company's public filings.
Company information
- Legal name
- VolitionRX Limited
- Ticker
- NYSE: VNRX
- Sector
- Healthcare
- Industry
- Medical Devices
- CEO
- Mr. Cameron Reynolds MBA
- Employees
- 57
- Headquarters
- 1489 West Warm Springs Road, Henderson, NV, United States
- Phone
- 512 774 8930
- Website
- volition.com
- IPO year
- 2015
- Market cap
- $6.60M
- SEC CIK
- 0000093314
Companies similar to VolitionRX
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| WOKWORK Medical Technology Group LTD Class A | 1.52 | -1.94% | $6.79M | vs VNRX |
| AMIXAutonomix Medical Inc. | 3.13 | -8.21% | $6.13M | vs VNRX |
| NVNOenVVeno Medical Corporation | 8.18 | -2.68% | $5.68M | vs VNRX |
| CODXCo-Diagnostics Inc. | 1.09 | -2.68% | $7.61M | vs VNRX |
| ICCMIceCure Medical Ltd. | 1.13 | -1.74% | $5.24M | vs VNRX |
| INBSIntelligent Bio Solutions Inc. | 1.57 | -1.26% | $5.21M | vs VNRX |
| VVOSVivos Therapeutics Inc. | 0.1495 | -0.99% | $5.02M | vs VNRX |
| TRIBTrinity Biotech plc ADR | 6.04 | -10.91% | $4.91M | vs VNRX |